✦ LIBER ✦

Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors

✍ Scribed by A. Osio; C. Mateus; J.-C. Soria; C. Massard; D. Malka; V. Boige; B. Besse; C. Robert

Book ID: 108670654
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 424 KB
Volume: 161
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2009.09214.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cutaneous side-effects in cancer patient

Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225

✍ K.J. Busam; P. Capodieci; R. Motzer; T. Kiehn; D. Phelan; A.C. Halpern 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 752 KB

Improvement of psoriasis and cutaneous s

Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis?

✍ E. Wierzbicka; J.M. Tourani; G. Guillet 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Effect of treatment with a colloidal oat

Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitors

✍ D. T. Alexandrescu; J. G. Vaillant; C. A. Dasanu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

Effects of long-term treatment withSeren

Effects of long-term treatment withSerenoa repens (Permixon®) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia

✍ Di Silverio, F.; Monti, S.; Sciarra, A.; Varasano, P.A.; Martini, C.; Lanzara, S 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 2 views

## Background: The n-hexane lipido-sterol extract of serenoa repens (lsesr, permixon, pierre fabre medicament, castres, france), a phytotherapeutic agent used in the treatment of benign prostatic hyperplasia (bph), has a multisite mechanism of action including inhibition of types 1 and 2 5alpha-red

Short- and long-term treatments with ilo

Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1

✍ D. Cozzolino; L. Coppola; S. Masi; T. Salvatore; F. C. Sasso; D. De Lucia; S. Ge 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 142 KB

Effect of a long-term methionyl growth h

Effect of a long-term methionyl growth hormone treatment on growth hormone releasing hormone-induced growth hormone secretion in patients with constitutional growth delay

✍ A. Sartorio; A. Conti; F. Morabito; G. Faglia 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 200 KB